Lysosomal modifications in astrocytes exposed to pathological α‐synuclein

In summary, our findings reveal that fibrillar αS induces significant, time-dependent changes in lysosomal enzyme activity and protein expression in astrocytes across multiple cellular models. We demonstrate that astrocytes possess a remarkable capacity to manage pathological αS from exogenous sources. Moreover, our results highlight the dynamic resilience of astrocytic lysosomes in recovering from αS-induced dysfunction. These findings emphasize the critical role of lysosomal function in astrocytes and suggest that targeting the astrocytic lysosomal system could enhance the degradation of pathological αS, potentially mitigating neurodegeneration and improving clinical outcomes in DLB and other α-synucleinopathies.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70855_102076
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lysosomal modifications in astrocytes exposed to pathological α‐synuclein

Jan Philipp Dobert, Magdalena M. Bolsinger, Denise Balta, Beate Winner et al.
Alzheimer s & Dementia
Parkinson's Disease Mechanisms and Treatments
article

Lysosomal modifications in astrocytes exposed to pathological α‐synuclein

Jan Philipp Dobert, Magdalena M. Bolsinger, Denise Balta, Beate Winner, Friederike Zunke, Philipp Arnold, Raul Moritz, Bruno Ghirotto
article en

Abstract

In summary, our findings reveal that fibrillar αS induces significant, time-dependent changes in lysosomal enzyme activity and protein expression in astrocytes across multiple cellular models. We demonstrate that astrocytes possess a remarkable capacity to manage pathological αS from exogenous sources. Moreover, our results highlight the dynamic resilience of astrocytic lysosomes in recovering from αS-induced dysfunction. These findings emphasize the critical role of lysosomal function in astrocytes and suggest that targeting the astrocytic lysosomal system could enhance the degradation of pathological αS, potentially mitigating neurodegeneration and improving clinical outcomes in DLB and other α-synucleinopathies.

Alzheimer s & DementiaVol. 21(S1)
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
Openalex Percentile: Top 31%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Lysosomal modifications in astrocytes exposed to pathological α‐synuclein — Jan Philipp Dobert, Magdalena M. Bolsinger, et al. · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS